APC anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody

Pricing & Availability
Clone
RB6-8C5 (See other available formats)
Regulatory Status
RUO
Other Names
Gr-1
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
Rb6-8C5_APC_Ly-6GslashLy-6C_Antibody_1_FC_090116
C57BL/6 mouse bone marrow stained with Ly-6G/Ly-6C APC (clone RB6-8C5, filled histogram) or APC Rat IgG2b, κ isotype control (open histogram).
  • Rb6-8C5_APC_Ly-6GslashLy-6C_Antibody_1_FC_090116
    C57BL/6 mouse bone marrow stained with Ly-6G/Ly-6C APC (clone RB6-8C5, filled histogram) or APC Rat IgG2b, κ isotype control (open histogram).
See APC spectral data
Cat # Size Price Quantity Check Availability Save
108411 25 µg $25.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108412 100 µg $85.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Gr-1 is a 21-25 kD protein also known as Ly-6G/Ly-6C. This myeloid differentiation antigen is a glycosylphosphatidylinositol (GPI)-linked protein expressed on granulocytes and macrophages. In bone marrow, the expression levels of Gr-1 directly correlate with granulocyte differentiation and maturation; Gr-1 is also transiently expressed on bone marrow cells in the monocyte lineage. Immature Myeloid Gr-1+ cells play a role in the development of antitumor immunity.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Raised against granulocytes of mouse origin
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C19. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A819. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.420.

The RB6-8C5 antibody has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. Additional reported applications (for relevant formats of this clone) include: in vitro complement-mediated cytotoxicity2, in vivo depletion3-5,9, immunoprecipitation1, immunohistochemical staining6 (including paraffin-embedded sections9,16,33-35, acetone-fixed frozen sections11 and zinc-fixed sections15), and Western blotting7. RB6-8C5 is not suitable for depletion of hepatic myeloid derived suppressor cells (MDSCs)20.

Special Note: For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 108436).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (IP)
  2. Brummer E, et al. 1984. J. Leukocyte Biol. 36:505. (CMCD)
  3. Stoppacciaro A, et al. 1993. J. Exp. Med. 178:151. (Deplete)
  4. Tumpey TM, et al. 1996. J. Virol. 70:898. (Deplete)
  5. Czuprynski CJ, et al. 1994. J. Immunol. 152:1836. (Deplete)
  6. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  7. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (WB)
  8. Engwerda CR, et al. 2004. Am. J. Pathol. 165:2123.
  9. Brown CR, et al. 2004. Infect. Immun. 72:4956. (Deplete, IHC)
  10. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) PubMed
  11. Li M, et al. 2006. P. Natl. Acad. Sci USA 103:11736. (IHC)
  12. Dzhagalov I, et al. 2007. Blood 109:1620. (FC) PubMed
  13. Fazilleau N, et al. 2007. Nature Immunol. 8:753. (FC) PubMed
  14. Heuser M, et al. 2007. Blood 110:1639. (FC) PubMed
  15. Wang T, et al. 2007. Infect. Immun. 75:1144. (IHC)
  16. Bosio CM, et al. 2007. J. Immunol. 178:4538. (IHC)
  17. Boehme SA, et al. 2009. Int. Immunol. 21:81. (IHC)
  18. Piao Y, et al. 2012. Neuro Oncol. 14:1379. PubMed
  19. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  20. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  21. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  22. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  23. Korrer MJ, et al. 2014. PLoS One. 9:91370. PubMed
  24. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  25. Collins C, et al. 2014. PNAS. 111:9899. PubMed
  26. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  27. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  28. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  29. Roderick JE, et al. 2014. PNAS. 111:14436. PubMed
  30. Distel E, et al. 2014. Circ Res. 115:759. PubMed
  31. Iwai H, et al. 2015. Tuberculosis. 95:246. PubMed
  32. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
  33. Whiteland J, et al. 1994 J Histochem Cytochem 43:3 (IHC-P)
  34. Brown C, et al. 2003 J Immunology 171:2 (IHC-P)
  35. Obregon-Henao A, et al. PLoS One 8:11 (IHC-P)
Product Citations
  1. Ruscher R, et al. 2018. Bio Protoc. 8:e2757. PubMed
  2. Skucha A, et al. 2018. Nat Commun. 9:1983. PubMed
  3. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  4. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  5. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  6. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  7. Gunn BM et al. 2018. Cell host & microbe. 24(2):221-233 . PubMed
  8. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  9. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  10. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  11. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  12. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  13. Mollaoglu G et al. 2018. Immunity. 49(4):764-779 . PubMed
  14. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  15. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  16. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  17. Zhu H, et al. 2018. Elife. 7:. PubMed
  18. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  19. Wang X, et al. 2018. Front Immunol. 9:2615. PubMed
  20. Gan T, et al. 2019. Front Microbiol. 9:3174. PubMed
  21. Okwan–Duodu D, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1125. PubMed
  22. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  23. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  24. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  25. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  26. Tamura M, et al. 2019. Sci Rep. 9:8171. PubMed
  27. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  28. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  29. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  30. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  31. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  32. Abraham TS, et al. 2019. J Immunol. 202:1301. PubMed
  33. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  34. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  35. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  36. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  37. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  38. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  39. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  40. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  41. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  42. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  43. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  44. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  45. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  46. Cabal-Hierro L, et al. 2020. Nat Commun. 11:1406. PubMed
  47. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  48. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  49. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  50. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  51. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  52. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  53. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  54. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  55. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  56. Zhou W, et al. 2019. Cell Syst. 0.597916667. PubMed
  57. Dzhagalov I, et al. 2007. Blood . 109:1620. PubMed
  58. Matsumoto M, et al. 2008. J Immunol. 181:3628. PubMed
  59. Pattabiraman D, et al. 2009. Mol Cancer Res. 1.317361111. PubMed
  60. Qiu X, et al. 2009. Infect Immun. 77:85. PubMed
  61. Ma C, et al. 2012. J Leukoc Biol. 92:1199. PubMed
  62. Kandasamy M, et al. 2013. PLoS Pathog. 9:e1003115. PubMed
  63. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  64. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  65. Korrer M, Routes J 2014. PLoS One. 9:91370. PubMed
  66. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  67. Collins C, et al. 2014. Proc Natl Acad Sci U S A. 111:9899. PubMed
  68. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  69. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  70. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  71. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  72. Distel E, et al. 2014. Circ Res . 115:759. PubMed
  73. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  74. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  75. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
  76. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  77. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  78. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  79. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  80. Lu W, et al. 2016. PLoS One. 11: 0149543. PubMed
  81. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  82. Jonas B, et al. 2016. PLoS One. 11: 0159189. PubMed
  83. Lim H, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.72. PubMed
  84. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  85. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  86. Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed
  87. Ouyang L, et al. 2016. Sci Rep. 6:39541. PubMed
  88. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  89. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  90. Zhao J, et al. 2020. Pharmacol Res Perspect. 8:e00660. PubMed
  91. Konishi H, et al. 2020. EMBO J. 39:e104464. PubMed
  92. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  93. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  94. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  95. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  96. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  97. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  98. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  99. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  100. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  101. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  102. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  103. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  104. Zeng F, et al. 2021. J Invest Dermatol. 596:141. PubMed
  105. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  106. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  107. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
RRID
AB_313376 (BioLegend Cat. No. 108411)
AB_313377 (BioLegend Cat. No. 108412)

Antigen Details

Structure
21-25 kD
Distribution

Granulocytes, monocytes

Cell Type
Granulocytes, Monocytes, Neutrophils
Biology Area
Immunology, Innate Immunity
Antigen References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399.
2. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
3. Goni O, et al. 2002. Int. Immunol. 14:1125.

Gene ID
17067 View all products for this Gene ID 546644 View all products for this Gene ID
UniProt
View information about Ly-6G/Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 09/01/2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account